It is generally accepted that anti-microbial therapy needs to be started for patients with AP when the infection with bacteria or fungi is highly suspected by the serum detection of microbial components such as endotoxin or β-d-glucan or by the presence of bacteremia or fungemia (King et al., 2005; Kochhar et al., 2009; Vege et al., 2009). The gene discussed is PPIB; the disease is alkaline phosphatase measurement.